1[1]Kato H. Cardiovascular problems in Kawasaki disease. In: Lue HC(eds). Pediatrics cardiology updates [ M]. Hong Kong: Springer,1997: 91 ～97
2[2]Laupland KB, Davies HD. Epiderniology, etiology, and management of Kawasaki disease: state of the art [ J ]. Pediatr Cardiol, 1999; 20: 177～183
3[3]Rowley AH, Shulman ST. Kawasaki syndrome[J ]. Pediatr Clin North Am, 1999; 46: 313～ 325
4[4]Fukunisbi M, Kikkawa M, Harnana K, et al . Prediction of non-re-sponsiveness to intravenous high-dose γ-globulin therapy in patients with Kawaeaki disease at onset [ J ]. J Pediatr, 2000; 137:172～ 176
5[5]Dale RC,Saleem MA,Daw S, et ,al . Treatment of severe complieated Kawasaki disease with oral prednisolone and aspirin[J ]. J Pediatr,2000; 137: 723～726
6[6]Shinohara M, Sone K, Tomomasa T, et al . Corticosteroids in the treatment of the acute phase of Kawasaki disease[J]. J Pediatr, 1999;135:465～469
8[8]Wright D, Newburger JW, Baker A, et al . Treatment of immune globulin- resistant Kawasaki disease with pulsed doses of corticosteroids[J]. J Pediatr, 1996; 123:146 ～149
9[9]Onouchi Z, Kawasaki T. Overview of pharmacological treatment of Kawasaki disease[J]. Drugs, 1999;58(5) :813～822
10[10]Takagi N, Kihara M, Yamaguchi S, et al . Plasma exchange in Kawaski disease[ J ]. Lancet, 1995; 346:1307
